A new method called target trial emulation (TTE) used real-world data to successfully replicate the findings of a previous clinical trial of Tecfidera (dimethyl fumarate) involving people with relapsing-remitting multiple sclerosis (RRMS), according to a study report. The approach also generated new evidence showing that Tecfidera outperformed glatiramer acetate (sold as Copaxone among others) in […]
The post New method confirms positive clinical trial results for MS drug Tecfidera appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com